Metabolic SyndromeNCT00350064
Impact of Exercise Training Intensity on Abdominal Visceral Fat and Risk Factors Associated With the Metabolic Syndrome
A study testing Exercise Training in people with Metabolic Syndrome, run by University of Virginia at 1 site in United States.
Trial summary
The purpose of this study is to determine if sixteen weeks of high intensity physical training is more effective than sixteen weeks of low intensity physical training in reducing abdominal fat and lowering risk factors associated with the metabolic syndrome. Read more about this study
- Who is it for?
- Ages 18 to 85 yearsHealthy volunteers can take part
- Conditions the study is for
- Metabolic Syndrome
- What is being tested?
- Exercise Training
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 165 participants
- Where
- 1 siteUnited States
- Study dates
- Apr 2004to Dec 2008
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 85 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Volunteers must have meet the definition of the metabolic syndrome (based on IDF consensus statement).
- Screening biochemical tests of liver, kidney, hematologic, metabolic (below) and thyroid function must be normal.
- The volunteer must be willing to:
- visit the outpatient GCRC or clinic once monthly for 16 weeks of intervention,
- participate in supervised exercise training (if assigned) and
- enter the inpatient GCRC for 2-3 days of more intensive studies at baseline and after 16 weeks of intervention. The subject must provide voluntary and fully informed written consent.
Who cannot join
- Type 1 diabetes,
- drug or alcohol abuse,
- psychosis,
- severe or untreated depression,
- dementia, polycythemia (hematocrit > 55%),
- clinically symptomatic coronary artery,
Show all 17Show fewer
- pulmonary or orthopedic disease (which would disallow exercise training),
- history of vascular or peripheral nerve trauma,
- lymph node dissection,
- anemia, uncontrolled hypertension (> 160/105 untreated or > 145/95 treated),
- allergic to octafluoropropane, or nitroglycerine,
- weight loss or gain of 2 kg or more within the preceding 10 days,
- investigational drug use within five biological half-lives,
- treatment with ACE inhibitors or ARBs, thiazolindiones,
- 1st or 2nd generation anti-psychotics insulin, or Viagra,
- unwillingness to provide written informed voluntary consent,
- pregnant, breast feeding or use hormonal birth control.
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Virginia General Clinical Research Center
Charlottesville, Virginia, 22904
About this study
The purpose of this study is to determine if sixteen weeks of high intensity physical training is more effective than sixteen weeks of low intensity physical training in reducing abdominal fat and lowering risk factors associated with the metabolic syndrome. Another aim of this study is to determine if high intensity physical training improves cognitive function.
- Conditions
- Metabolic Syndrome
- Being tested
- Exercise Training
- Keywords
- Metabolic Syndrome, Obesity, Exercise, Diabetes, Physical Activity
- Medical subject headings
- Metabolic Syndrome, Obesity, Motor Activity, Diabetes Mellitus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Exercise TrainingBehavioural
16 weeks of aerobic exercise training at two different intensities
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Abdominal Visceral Fat
Measured: before and after 16 weeks
Secondary outcomes (14)
VO2peak
Measured: before and after 16 weeks
% Body Fat
Measured: before and after 16 weeks
Insulin
Measured: before and after 16 weeks
FFA
Measured: before and after 16 weeks
Glucose
Measured: before and after 16 weeks
Hba1c
Measured: before and after 16 weeks
Cholesterol
Measured: before and after 16 weeks
CRP
Measured: before and after 16 weeks
IL6
Measured: before and after 16 weeks
TNF
Measured: before and after 16 weeks
Homocysteine
Measured: before and after 16 weeks
Adiponectin
Measured: before and after 16 weeks
Adhesion Molecules
Measured: before and after 16 weeks
Endothelial Function
Measured: before and after 16 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Jul 2006 (estimated)
- Study startApr 2004
- Primary completionJun 2006 (estimated)
- Study completionDec 2008 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Metabolic SyndromeStudies of the same condition, open and under way.
- More trials run by University of VirginiaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- None (open label)
- Enrolment
- 165 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Virginia
- Sponsor type
- University, hospital or other
- Collaborators
- National Center for Research Resources (NCRR)
- Investigators
- Arthur Weltman, PhD, Principal investigator, University of VirginiaBrian A Irving, PhD, Study director, University of Virginia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00350064
- Sponsor's protocol ID
- UVAHIC11145
- Status last verified
- Aug 2008
- First submitted
- 6 Jul 2006
- Last updated
- 8 Aug 2008
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Aug 2008. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Exercise Training Intensity on Abdominal Visceral Fat and Risk Factors Associated With the Metabolic Syndrome
- ClinicalTrials.gov ID
- NCT00350064
- Acronym / sponsor ID
- UVAHIC11145
- Conditions
- Metabolic Syndrome
- Keywords
- Metabolic Syndrome, Obesity, Exercise, Diabetes, Physical Activity
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 165 participants (estimated)
- Lead sponsor
- University of VirginiaUniversity, hospital or other
- Collaborators
- National Center for Research Resources (NCRR)
- Study start
- Apr 2004
- Primary completion
- Jun 2006 (estimated)
- Study completion
- Dec 2008 (estimated)
- First posted
- 10 Jul 2006 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine if sixteen weeks of high intensity physical training is more effective than sixteen weeks of low intensity physical training in reducing abdominal fat and lowering risk factors associated with the metabolic syndrome. Another aim of this study is to determine if high intensity physical training improves cognitive function.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- None (open label)
Who may qualify
- Ages
- 18 to 85 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Volunteers must have meet the definition of the metabolic syndrome (based on IDF consensus statement).
- Screening biochemical tests of liver, kidney, hematologic, metabolic (below) and thyroid function must be normal.
- The volunteer must be willing to:
Key exclusion criteria (17 listed)
- Type 1 diabetes,
- drug or alcohol abuse,
- psychosis,
- severe or untreated depression,
- dementia, polycythemia (hematocrit > 55%),
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Exercise Training16 weeks of aerobic exercise training at two different intensities | Behavioural | – |
Primary outcome
Change in Abdominal Visceral Fat
Time frame: before and after 16 weeks
14 secondary outcomes
VO2peak
Time frame: before and after 16 weeks
% Body Fat
Time frame: before and after 16 weeks
Insulin
Time frame: before and after 16 weeks
FFA
Time frame: before and after 16 weeks
Glucose
Time frame: before and after 16 weeks
Hba1c
Time frame: before and after 16 weeks
Cholesterol
Time frame: before and after 16 weeks
CRP
Time frame: before and after 16 weeks
IL6
Time frame: before and after 16 weeks
TNF
Time frame: before and after 16 weeks
Homocysteine
Time frame: before and after 16 weeks
Adiponectin
Time frame: before and after 16 weeks
Adhesion Molecules
Time frame: before and after 16 weeks
Endothelial Function
Time frame: before and after 16 weeks
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Aug 2008.
Related trials for Metabolic Syndrome
RecruitingObservational study
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
Fanconi Anemia, Inherited Bone Marrow Failure Syndrome
Not yet recruitingPhase 2
Osilodrostat for Glycemic Control in Mild Autonomous Cortisol Secretion (MACS) With Difficult-To-Control Type 2 Diabetes - A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
Mild Autonomous Cortisol Secretion (MACS), Diabetes Mellitus (Type 2)
Active, not recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
Not yet recruitingObservational study
Clinical Genetics Branch Eligibility Screening Survey
Melanoma, Li-Fraumeni Syndrome
Not yet recruitingPhase 2
Effects of Meal Macronutrients on Postprandial Lipids
Nephrotic Syndrome, Lipodystrophy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Arthur Weltman, PhD principal investigator
University of Virginia
Brian A Irving, PhD study director
University of Virginia
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exercise Training in people with Metabolic Syndrome, run by University of Virginia at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 8 Aug 2008. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Abdominal Visceral Fat (time frame: before and after 16 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Aug 2008.